Literature DB >> 16288730

Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease.

Petronila Penela1, Cristina Murga, Catalina Ribas, Antonio S Tutor, Sandra Peregrín, Federico Mayor.   

Abstract

The G protein-coupled receptor kinases (GRKs) participate with arrestins in the regulation and signal propagation of multiple G protein-coupled receptors (GPCR) of key physiological and pharmacological relevance in the cardiovascular system. The complex mechanisms of regulation of GRK expression, degradation and function are being unveiled gradually. The levels of these kinases are known to change in pathological situations such as heart failure, hypertrophy and hypertension, and in animal models of these diseases. A better understanding of the mechanisms underlying these changes and of how these alterations participate in the triggering or progression of cardiovascular disease may contribute to the design of novel diagnostic and therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288730     DOI: 10.1016/j.cardiores.2005.09.011

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  67 in total

Review 1.  Alan [corrected] N. Epstein award: Intracellular signaling and ingestive behaviors.

Authors:  Derek Daniels
Journal:  Physiol Behav       Date:  2010-03-25

2.  Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment.

Authors:  M Rafiuddin Ahmed; Evgeny Bychkov; Vsevolod V Gurevich; Jeffrey L Benovic; Eugenia V Gurevich
Journal:  J Neurochem       Date:  2007-11-07       Impact factor: 5.372

Review 3.  Seven-transmembrane receptors and ubiquitination.

Authors:  Sudha K Shenoy
Journal:  Circ Res       Date:  2007-04-27       Impact factor: 17.367

Review 4.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

Review 5.  Targeted gene therapy for the treatment of heart failure.

Authors:  Kleopatra Rapti; Antoine H Chaanine; Roger J Hajjar
Journal:  Can J Cardiol       Date:  2011 May-Jun       Impact factor: 5.223

6.  Structure-Based Design of Selective, Covalent G Protein-Coupled Receptor Kinase 5 Inhibitors.

Authors:  Rachel A Rowlands; M Claire Cato; Helen V Waldschmidt; Renee A Bouley; Qiuyan Chen; Larisa Avramova; Scott D Larsen; John J G Tesmer; Andrew D White
Journal:  ACS Med Chem Lett       Date:  2019-11-12       Impact factor: 4.345

Review 7.  G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function.

Authors:  Douglas G Tilley
Journal:  Circ Res       Date:  2011-07-08       Impact factor: 17.367

Review 8.  The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets.

Authors:  Petronila Penela; Cristina Murga; Catalina Ribas; Vanesa Lafarga; Federico Mayor
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 9.  Beta-adrenoceptor blocker treatment and the cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure.

Authors:  Otto-Erich Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-11       Impact factor: 3.000

10.  Adaptor protein-2 interaction with arrestin regulates GPCR recycling and apoptosis.

Authors:  Brant M Wagener; Nicole A Marjon; Chetana M Revankar; Eric R Prossnitz
Journal:  Traffic       Date:  2009-06-15       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.